Evidence map›Paper›PMID 40926205›Full record

ArticleBMC public health2025

The interplay of influenza and COVID-19 in Germany, January 2020 - December 2022: a study of competitive disease dynamics with quarantine measures and partial cross-immunity.

Anna Daniel Fome, Isti Rodiah, Wolfgang Bock, Berit Lange, Axel Klar

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Daniel FomeDepartment of Mathematics, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Str.48, Kaiserslautern, 67663, Germany.
Isti RodiahDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, Braunschweig, 38124, Germany.
Wolfgang BockDepartment of Mathematics, Linnaeus University, Universitetsplatsen 1, Växjö, 35252, Sweden. wolfgang.bock@lnu.se.
Berit LangeDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, Braunschweig, 38124, Germany.
Axel KlarDepartment of Mathematics, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Str.48, Kaiserslautern, 67663, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We study the dynamics of coexisting influenza and SARS-CoV-2 by adapting a well-established age-specific COVID-19 model to a multi-pathogen framework. Sensitivity analysis and adjustment of the model to real-world data are used to investigate the influence of age-related factors on disease dynamics. Our findings underscore the critical role that transmission rates play in shaping the spread of influenza and COVID-19. Furthermore, our analysis highlights the significant interaction between influenza and SARS-CoV-2 transmission rates, particularly in scenarios with partial cross-immunity. This underscores the importance of comprehensive interventions that simultaneously target both pathogens to effectively control their spread in coexisting environments. Our results demonstrate the importance of age-structured models in capturing the dynamics of influenza and COVID-19, underscoring the importance of accounting for age structure. Notable disparities emerge in estimated transmission rates between single-pathogen and multi-pathogen models, shedding light on the complex interactions between pathogens and their impacts on disease transmission across different age groups.

Indexed as

COVID-19Influenza, HumanQuarantineAdolescentAdultAgedAge FactorsChildChild, PreschoolGermanyHumansInfantMiddle AgedSARS-CoV-2Young AdultAge-stratified modelCo-existenceCompetitionCOVID-19Cross-immunityInfluenzaMulti-pathogen

Identifiers

PMID40926205
PMCPMC12418641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.